| |
| |
|
| Insider
Information: |
Haseltine William A |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,818,653 |
|
|
Indirect Shares
|
335,731 |
|
|
| Direct
Value |
$2,849 |
|
|
|
Indirect Value
|
$130,618 |
|
|
| Total
Shares |
3,154,384 |
|
|
| Total
Value |
$133,467 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Chairman & CEO, Director |
2004-02-13 |
2,811,548 |
2004-02-13 |
10,000 |
Premium* |
|
|
Acasti Pharma Inc |
ACST |
Director |
2021-08-27 |
7,105 |
2021-08-27 |
325,731 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACST |
Acasti Pharma Inc |
Director |
– • – |
2021-08-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,105 |
|
% |
|
| ACST |
Acasti Pharma Inc |
Director |
– • – |
2021-08-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
325,731 |
|
% |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(1) |
0 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
S |
$13.24 |
$9,006 |
I/I |
(677) |
1 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1 |
2,811,548 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
S |
$12.91 |
$98,094 |
I/I |
(7,548) |
678 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
S |
$12.80 |
$74,294 |
I/I |
(5,774) |
8,226 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
S |
$13.14 |
$469,478 |
D/D |
(35,520) |
2,811,547 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-13 |
4 |
S |
$12.80 |
$2,484,890 |
D/D |
(192,481) |
2,847,067 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
S |
$13.42 |
$165,528 |
I/I |
(12,259) |
14,001 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
S |
$13.38 |
$164,237 |
I/I |
(12,258) |
26,260 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
3,039,547 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
S |
$13.38 |
$3,242,672 |
D/D |
(241,083) |
3,049,547 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
S |
$13.00 |
$312,284 |
I/I |
(23,482) |
38,518 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4 |
S |
$13.00 |
$3,070,948 |
D/D |
(230,918) |
3,290,630 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4/A |
S |
$13.42 |
$165,528 |
I/I |
(12,259) |
14,000 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4/A |
D |
$0.00 |
$0 |
I/I |
(1) |
26,259 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Chairman & CEO |
• • – |
2004-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
1 |
3,039,548 |
|
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
